Preview

Системные гипертензии

Расширенный поиск

Низкая физическая активность как фактор риска сердечно-сосудистой заболеваемости и смертности

https://doi.org/10.26442/2075-082X_2018.3.14-20

Аннотация

В обзоре приведен анализ результатов различных клинических исследований, посвященных особенностям влияния физической активности на функциональное состояние сердечно-сосудистой системы, и данные, свидетельствующие о том, что низкая физическая активность наряду с психосоциальными факторами, курением, избыточным потреблением алкоголя, нездоровым питанием, ожирением, артериальной гипертензией, сахарным диабетом является одним из наиболее важных факторов риска развития сердечно-сосудистых заболеваний. Приводится сравнительная характеристика показателей сердечно-сосудистой заболеваемости и смертности в зависимости от уровня физической активности среди мужского и женского населения стран с различным социально-экономическим уровнем. Сделан вывод о необходимости повысить приверженность населения стран с разным уровнем доходов разнообразным видам физической активности с целью снижения сердечно-сосудистой заболеваемости, общей и сердечно-сосудистой смертности.

Об авторах

Кристина Евгеньевна Кривошапова
ФГБНУ НИИ КПССЗ
Россия


Дарья Павловна Цыганкова
ФГБНУ НИИ КПССЗ
Россия


Ольга Леонидовна Барбараш
ФГБНУ НИИ КПССЗ; ФГБОУ ВО КемГМУ
Россия


Список литературы

1. Naghavi M, Wang H, Lozano R et al. Global, regional, and national age-sex specific all-cause and cause-specific mortality for 240 causes of death, 1990-2013: a systematic analysis for the Global Burden of Disease Study 2013. Lancet 2015; 385: 117-71.

2. Townsend N, Wilson L, Bhatnagar P et al. Cardiovascular disease in Europe: epidemiological update 2016. Eur Heart J 2016; 37 (42): 3232-45.

3. Roth G.A, Forouzanfar M.H, Moran A.E et al. Demographic and epidemiologic drivers of global cardiovascular mortality. N Engl J Med 2015; 372: 1333-41.

4. Benziger C.P, Roth G.A, Moran A.E. The Global Burden of Disease Study and the preventable burden of NCD. Glob Heart 2016; 11: 393-7.

5. Beaglehole R, Bonita R. Global public health: a scorecard. Lancet 2008; 372: 1988-96.

6. Mokdad A.H, Marks J.S, Stroup D.F, Gerberding J.L. Actual causes of death in the United States, 2000. JAMA 2004; 291: 1238-45.

7. Yusuf S, Hawken S, Ounpu S et al, on behalf of the INTERHEART Study Investigators. Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART Study): case-control study. Lancet 2004; 364: 937-52.

8. O’Donnell M, Xavier D, Liu L, Zhang H. Risk factors for ischaemic and intracerebral haemorrhagic stroke in 22 countries (the INTERSTROKE Study): a case-control study Reference. Lancet 2010; 376: 112-23.

9. Johnsen A.M, Alfredsson L, Knutsson A et al. Association between occupational physical activity and myocardial infarction: a prospective cohort study. BMJ 2016; 6: 012692.

10. Бойцов С.А., Баланова Ю.А., Шальнова С.А. и др. Артериальная гипертония среди лиц 25-64 лет: распространенность, осведомленность, лечение и контроль. По материалам исследования ЭССЕ. Кардиоваск. терапия и профилактика. 2014; 13 (4): 4-14.

11. Муромцева Г.А., Концевая А.В., Константинов В.В. и др. Распространенность факторов риска неинфекционных заболеваний в российской популяции в 2012-2013 гг. Результаты исследования ЭССЕ-РФ. Кардиоваск. терапия и профилактика. 2014; 13 (6): 4-11

12. Метельская В.А., Шальнова С.А., Деев А.Д. и др. Анализ распространенности показателей, характеризующих атерогенность спектра липопротеинов у жителей Российской Федерации (по данным исследования ЭССЕ-РФ). Профилактич. медицина. 2016; 1 (19): 15-23

13. Дедов И.И., Шестакова М.В., Галстян Г.Р. Распространенность сахарного диабета 2-го типа у взрослого населения России (исследование NATION). Сахарный диабет. 2016; 19 (2): 104-12.

14. Шальнова С.А., Деев А.Д., Метельская В.А. и др. Информированность и особенности терапии статинами у лиц с различным сердечно-сосудистым риском: исследование ЭССЕ-РФ. Кардиоваск. терапия и профилактика. 2016; 4 (15): 29-37.

15. Ferrari R, Ford I, Greenlaw N et al. Geographical variations in the prevalence and management of cardiovascular risk factors in outpatients with CAD: Data from the contemporary CLARIFY registry. Eur J Prev Cardiol 2015; 22 (8): 1056-65.

16. Dumith S.C, Hallal P.C, Reis R.S, Kohl H.W. Worldwide prevalence of physical inactivity and its association with human development index in 76 countries. Prev Med 2011; 53 (1-2): 24-8.

17. Löllgen H, Böckenhoff A, Knapp G. Physical activity and all-cause mortality: An updated meta-analysis with different intensity categories. Int J Sports Med 2009; 30: 213-24.

18. Nocon M, Hiemann T, Muller-Riemenschneider F et al. Association of physical activity with all-cause and cardiovascular mortality: a systematic review andmeta-analysis. Eur J Cardiovasc Prev Rehabil 2008; 15: 239-46.

19. Samitz G, Egger M, Zwahlen M. Domains of physical activity and all-cause mortality: systematic review and dose-response meta-analysis of cohort studies. Int J Epidemiol 2011; 40: 1382-400.

20. Löllgen H, Löllgen D. Risk reduction in cardiovascular diseases by physical activity. Internist 2012; 53 (1): 20-9.

21. Blumenthal J.A, Babyak M.A, Carney R.M et al. Exercise, depression, and mortality after myocardial infarction in the ENRICHD trial. Med Sci Sports Exerc 2004; 36 (5): 746-55.

22. Wannamethee S.G, Shaper A.G, Walker M. Physical activity and mortality in older men with diagnosed coronary heart disease. Circulation 2000; 102: 1358-63.

23. Janssen I, C.J J. Influence of physical activity on mortality in elderly with coronary artery disease. Med Sci Sports Exerc 2006; 38 (3): 418-23.

24. Al-Khalili F, Janszky I, Andersson A et al. Physical activity and exercise performance predict long-term prognosis in middle-aged women surviving acute coronary syndrome. J Intern Med 2007; 261: 178-87.

25. Moholdt T, Wisloff U, Nilsen T.I.L, Slordahl S.A. Physical activity and mortality in men and women with coronary heart disease: a prospective population-based cohort study in Norway (the HUNT study). Eur J Cardiovasc Prev Rehabil 2008; 15: 639-45.

26. Apullan F.J, Bourassa M.G, Tardif J.C et al. Usefulness of self-reported leisure-time physical activity to predict long-term survival in patients with coronary heart disease. Am J Cardiol 2008; 102: 375-9.

27. Gerber Y, Myers V, Goldbourt U et al. Long-term trajectory of leisure time physical activity and survival after first myocardial infarction: a population-based cohort study. Eur J Epidemiol 2011; 26: 109-16.

28. Mons U, Hahmann H, Brenner H. A reverse J-shaped association of leisure time physical activity with prognosis in patients with stable coronary heart disease: evidence from a large cohort with repeated measurements. Heart 2014; 100: 1043-9.

29. Yu C, Li L.S, Ho H.H, Lau C. Long-term changes in exercise capacity, quality of life, body anthropometry, and lipid profiles after a cardiac rehabilitation program in obese patients with coronary heart disease. Am J Cardiol 2003; 91: 321-5.

30. Shibata Y, Hayasaka S, Yamada T et al. Physical activity and risk of fatal or non-fatal cardiovascular disease among CVD survivors - the JMS cohort study. Circ J 2011; 75: 1368-72.

31. Gregg E.W, Cauley J.A, Stone K et al. Relationship of changes in physical activity and mortality among older women. JAMA 2003; 289: 2379-86.

32. Kushi L.H, Fee R.M, Folsom A.R et al. Physical activity and mortality in postmenopausal women. JAMA 1997; 277: 1287-92.

33. Schooling C.M, Lam T.H, Li Z.B et al. Obesity, physical activity, and mortality in a prospective Chinese elderly cohort. Arch Intern Med 2006; 166: 1498-504.

34. Thompson P.D, Buchner D, Pina I.L et al. Exercise and physical activity in the prevention and treatment of atherosclerotic cardiovascular disease: a statement from the Council on Clinical Cardiology (Subcommittee on Exercise, Rehabilitation, and Prevention) and the Council on Nutrition, Physical Activity, and Metabolism (Subcommittee on Physical Activity). Circulation 2003; 107: 3109-16.

35. U.S. Department of Health and Human Services, Rdt. Physical activity and health: a report of the surgeon general. Atlanta: U.S Department of Health and Human Services. Centers for Disease Control and Prevention National Center for Chronic Disease and Health Promotion, 1996.

36. Hollmann W, Hettinger T.H. Sportmedizin. Grundlagen for Arbeit, Training und Preventivmedizin, vollig neu bearbeitete und erweiterte Auflage ed, vol. 4. Stuttgart/New York: Schattauer, 2000.

37. Irwin M.L, Yasui Y, Ulrich C.M et al. Effect of exercise on total and intra-abdominal body fat in postmenopausal women: a randomized controlled trial. JAMA 2003; 289 (3): 323-30.

38. Swain D.P, Franklin B.A. Comparison of cardioprotective benefits of vigorous versus moderate intensity aerobic exercise. Am J Cardiol 2006; 97 (1): 141-7.

39. Tikkanen E, Gustafsson S, Ingelsson E. Associations of fitness, physical activity, strength, and genetic risk with cardiovascular disease. Longitudinal analyses in the UK Biobank Study. Circulation 2018; 137: 2583-91.

40. Manson J.E, Greenland P, LaCroix A.Z et al. Walking compared with vigorous exercise for the prevention of cardiovascular events in women. N Engl J Med 2002; 347 (10): 716-25.

41. Scott A.L, Weihong H, Sumathy R et al. The effect of physical activity on mortality and cardiovascular disease in 130 000 people from 17 high-income,middle-income, and low-income countries: the PURE study. Lancet 2017; 390: 2643-54.

42. Lee I.M, Shiroma E.J, Lobelo F et al. Effect of physical inactivity on major non-communicable diseases worldwide: an analysis of burden of disease and life expectancy. Lancet 2012; 380: 219-29.

43. Talbot L.A, Morrell C.H, Metter E.J, Fleg J.L. Comparison of cardiorespiratory fitness versus leisure time physical activity as predictors of coronary events in men aged < or = 65 years and >65 years. Am J Cardiol 2002; 89 (10): 1187-92.

44. Kelly P, Kahlmeier S, Gotschi T et al. Systematic review and meta-analysis of reduction in all-cause mortality from walking and cycling and shape of dose response relationship. Int J Behav Nutr Phys Act 2014; 11: 132.

45. Noda H, Iso H, Toyoshima H et al. Walking and sports participation and mortality from coronary heart disease and stroke. J Am Coll Cardiol 2005; 46 (9): 1761-7.

46. Myers J, Kaykha A, George S et al. Fitness versus physical activity patterns in predicting mortality in men. Am J Med 2004; 117: 912-8.

47. Oguma Y, Shinoda-Tagawa T. Physical activity decreases cardiovascular disease risk in women: review and meta-analysis. Am J Prev Med 2004; 26 (5): 407-18.

48. Kohl H.W, Physical activity and cardiovascular disease: evidence for a dose response. Med Sci Sports Exerc 2001; 33 (6 Suppl.): 472-83.

49. Williams P.T. Physical fitness and activity as separate heart disease risk factors: a meta-analysis. Med Sci Sports Exerc 2001; 33 (5): 754-61.

50. Sabia S, Dugravot A, Kivimaki M et al. Effect of intensity and type of physical activity on mortality: results from the Whitehall II cohort study. Am J Public Health 2012; 102: 698-704.

51. Rastogi T, Vaz M, Spiegelman D et al. Physical activity and risk of coronary heart disease in India. Int J Epidemiol 2004; 33 (4): 759-67.

52. Sundquist K, Qvist J, Johansson S.E, Sundquist J. The long-term effect of physical activity on incidence of coronary heart disease: a 12-year follow-up study. Prev Med 2005; 41 (1): 219-25.

53. Folsom A.R, Arnett D.K, Hutchinson R.G. et al. Physical activity and incidence of coronary heart disease in middle-aged women and men. Med Sci Sports Exerc 1997; 29 (7): 901-9.

54. Fransson E, De F.U, Ahlbom A et al. The risk of acute myocardial infarction: interactions of types of physical activity. Epidemiology 2004; 15 (5): 573-82.

55. Sesso H.D, Paffenbarger R.S, Ha T, Lee I.M. Physical activity and cardiovascular disease risk in middle-aged and older women. Am J Epidemiol 1999; 150 (4): 408-16.

56. LaCroix A.Z, Leveille S.G, Hecht J.A et al. Does walking decrease the risk of cardiovascular disease hospitalizations and death in older adults? J Am Geriatr Soc 1996; 44 (2): 113-20.

57. Matthews C.E, Jurj A.L, Shu X.O et al. Influence of exercise, walking, cycling, and overall nonexercise physical activity on mortality in Chinese women. Am J Epidemiol 2007; 165 (12): 1343-50.

58. Lam T.H, Ho S.Y, Hedley A.J et al. Leisure time physical activity and mortality in Hong Kong: case-control study of all adult deaths in 1998. Ann Epidemiol 2004; 14 (6): 391-8.

59. Paffenbarger R.S, Hyde R.T, Wing A.L et al. The association of changes in physical-activity level and other lifestyle characteristics with mortality among men. N Engl J Med 1993; 328 (8): 538-45.

60. Wannamethee S.G, Shaper A.G, Walker M. Changes in physical activity, mortality, and incidence of coronary heart disease in older men. Lancet 1998; 351 (9116): 1603-8.

61. Wendel-Vos G.C, Schuit A.J, Feskens E.J et al. Physical activity and stroke. A meta-analysis of observational data. Int J Epidemiol 2004; 33 (4): 787-98.

62. Lee C.D, Folsom A.R, Blair S.N. Physical activity and stroke risk: a meta-analysis. Stroke 2003; 34 (10): 2475-81.

63. Gillum R.F, Mussolino M.E, Ingram D.D. Physical activity and stroke incidence in women and men. The NHANES I Epidemiologic Follow-up Study. Am J Epidemiol 1996; 143 (9): 860-9.

64. Housley E, Leng G.C, Donnan P.T, Fowkes F.G. Physical activity and risk of peripheral arterial disease in the general population: Edinburgh Artery Study. J Epidemiol Community Health 1993; 47 (6): 475-80.

65. Sieminski D.J, Gardner A.W. The relationship between free-living daily physical activity and the severity of peripheral arterial occlusive disease. Vasc Med 1997; 2 (4): 286-91.

66. Gardner A.W, Womack C.J, Sieminski D.J et al. Relationship between free-living daily physical activity and ambulatory measures in older claudicants. Angiology 1998; 49 (5): 327-37.

67. Gardner A.W, Montgomery P.S, Killewich L.A. Natural history of physical function in older men with intermittent claudication. J Vasc Surg 2004; 40 (1): 73-8.

68. Sattelmair J, Pertman J, Ding E.L et al. Dose response between physical activity risk of coronary heart disease: a meta-analysis. Circulation 2011; 124: 789-95.

69. Cornelissen V.A, Fagard R.H. Effects of endurance training on blood pressure, blood pressure-regulating mechanisms, and cardiovascular risk factors. Hypertension 2005; 46 (4): 667-75.

70. Stamler J, Rose G, Stamler R et al. INTERSALT study findings. Public health and medical care implications. Hypertension 1989; 14 (5): 570-7.

71. Kelley G.A, Kelley K.A, Tran Z.V. Aerobic exercise and resting blood pressure: a meta-analytic review of randomized, controlled trials. Prev Cardiol 2001; 4 (2): 73-80.

72. Whelton S.P, Chin A, Xin X, He J. Effect of aerobic exercise on blood pressure: a meta-analysis of randomized, controlled trials. Ann Intern Med 2002; 136 (7): 493-503.

73. Fagard R.H, Cornelissen V.A. Effect of exercise on blood pressure control in hypertensive patients. Eur J Cardiovasc Prev Rehabil 2007; 14 (1): 12-7.

74. Kodama S, Tanaka S, Saito K et al. Effect of aerobic exercise training on serum levels of high-density lipoprotein cholesterol: a meta-analysis. Arch Intern Med 2007; 167 (10): 999-1008.

75. Slentz C.A, Houmard J.A, Johnson J.L et al. Inactivity, exercise training and detraining, and plasma lipoproteins. STRRIDE: a randomized, controlled study of exercise intensity and amount. J Appl Physiol 2007; 103 (2): 432-42.

76. Autenrieth C.S, Baumert J, Baumeister S.E et al. Association between domains of physical activity and all-cause, cardiovascular and cancer mortality. Eur J Epidemiol 2011; 26: 91-9.

77. Nocon M, Hiemann T, Muller-Riemenschneider F et al. Association of physical activity with all-cause and cardiovascular mortality: a systematic review and meta-analysis. Eur J Cardiovasc Prev Rehabil 2008; 15: 239-46.

78. Milton K, Macniven R, Bauman A. Review of the epidemiological evidence for physical activity and health from low- and middle-income countries. Glob Pub Health 2014; 9: 369-81.

79. Palafox B, McKee M, Balabanova D et al. Wealth and cardiovascular health: a cross-sectional study of wealth-related inequalities in the awareness, treatment and control of hypertension in high-, middle- and low-income countries. Int J Equity Health 2016; 15 (1): 199.

80. World Bank. How we classify countries. Accessed 2011.

81. Craig C.L, Marshall A.L, Sjostrom M et al. International physical activity questionnaire: 12-country reliability and validity. Med Sci Sports Exerc 2003; 35: 1381-95.

82. Miller V, Yusuf S, Chow C.K et al. Availability, affordability, and consumption of fruits and vegetables in 18 countries across income levels: findings from the Prospective Urban Rural Epidemiology (PURE) study. Lancet Glob Health 2016; 4: 695-703.

83. Khatib R, McKee M, Shannon H et al. Availability and affordability of cardiovascular disease medicines and their effect on use in high-income, middle-income, and low-income countries: an analysis of the PURE study data. Lancet 2016; 387: 61-9.

84. Etemadi A, Abnet C.C, Kamangar F et al. Impact of body size and physical activity during adolescence and adult life on overall and cause-specific mortality in a large cohort study from Iran. Eur J Epidemiol 2014; 29: 95-109.

85. Csizmadi I, Robson P.J, Neilson H.K. Influence of exercise, walking, cycling, and overall nonexercise physical activity on mortality in Chinese women. Am J Epidemiol 2007; 166 (11): 1355-6.

86. Arem H, Moore S.C, Patel A et al. Leisure time physical activity and mortality: a detailed pooled analysis of the dose-response relationship. JAMA Intern Med 2015; 175: 959-67.

87. Yu R, Leung J, Woo J. Housework reduces all-cause and cancer mortality in Chinese men. PLoS One 2013; 8: 61529.

88. Wu C.Y, Hu H.Y, Chou Y.C et al. The association of physical activity with all-cause, cardiovascular, and cancer mortalities among older adults. Prev Med 2015; 72: 23-9.

89. Vaes A.W, Garcia-Aymerich J, Marott J.L et al. Changes in physical activity and all-cause mortality in COPD. Eur Respir J 2014; 44: 1199-209.

90. Reis R.S, Salvo D, Ogilvie D, et al. Scaling up physical activity interventions worldwide: stepping up to larger and smarter approaches to get people moving. Lancet 2016; 388: 1337-48.


Рецензия

Для цитирования:


Кривошапова К.Е., Цыганкова Д.П., Барбараш О.Л. Низкая физическая активность как фактор риска сердечно-сосудистой заболеваемости и смертности. Системные гипертензии. 2018;15(3):14-20. https://doi.org/10.26442/2075-082X_2018.3.14-20

For citation:


Krivoshapova K.E., Tsygankova D.P., Barbarash O.L. Physical inactivity as a risk factor for cardiovascular morbidity and mortality. Systemic Hypertension. 2018;15(3):14-20. https://doi.org/10.26442/2075-082X_2018.3.14-20

Просмотров: 1


Creative Commons License
Контент доступен под лицензией Creative Commons Attribution 4.0 License.


ISSN 2075-082X (Print)
ISSN 2542-2189 (Online)